Faculty profile

Sheela Ramanathan

ResearcherImmunologie-Biologie CellulaireUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Sheela Ramanathan

Researcher

Immunologie-Biologie Cellulaire

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
27 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 11 research grants (8 CIHR, 3 NSERC), most recently in 2025.
Supervisor on 1 trainee award (1 CIHR), most recently in 2009.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Immune Responses Long Covid Interleukin-15 Chronic Inflammation Obesity Antigen Presentation Cd8+ T Cells Mhc Class-I

Latest papers

Effect of probiotics on humoral responses to COVID-19 vaccination in older adults: a randomized, placebo-controlled trial (PIRATES-COV study).
Gut microbes · 2026 · senior author
Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.
Cancers · 2026 · senior author
NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.
Immunotherapy advances · 2026

All 73 publications

Latest funding

Development of an NLRC5-based broad spectrum immunotherapeutic for immune evasive cancers
CIHR · 2025 · Principal investigator
$1,181,926
Immunopathogenic mechanisms of IL-15 in intestinal inflammation
CIHR · 2024 · Principal investigator
$1,055,700
CIACCO- a multidisciplinary symposium on Cytokines, Immunity, Ageing, CanCer and Obesity
CIHR · 2024 · Co-investigator
$12,000

All 21 grants and awards

73 publications.

Effect of probiotics on humoral responses to COVID-19 vaccination in older adults: a randomized, placebo-controlled trial (PIRATES-COV study).

Pasquier JC, Chaillet N, Plourde M, Boivin G, Hamelin MÈ, Allard-Chamard H, Piché A, Baron G, Laforest-Lapointe I, Généreux M, Mâsse B, Robitaille J, Beaulieu JF, Fülöp T, Bilodeau S, Ramanathan S

Gut microbes2026Senior author

DOI: 10.1080/19490976.2026.2699456 PMID: 42520140

Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.

Rexhepi F, Ali Akbari S, Moradzad M, Khodayari S, Shukla A, Demontier E, Lucier JF, Armas Cayarga A, Allard-Chamard H, Ilangumaran S, Ramanathan S

Cancers2026Senior author

DOI: 10.3390/cancers18152499 PMID: 42588715

NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.

Shukla A, Moradzad M, Quenum AJI, Lucier JF, Armas Cayarga A, Lévesque D, Boisvert FM, Kufer TA, Ramanathan S, Ilangumaran S

Immunotherapy advances2026

DOI: 10.1093/immadv/ltag010 PMID: 42326466

Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.

Chowdhury MMH, Fontaine MN, Lord SE, Lucier JF, Allard-Chamard H, Ilangumaran S, Piché A, Dionne IJ, Ramanathan S

Frontiers in sports and active living2026Senior author

DOI: 10.3389/fspor.2026.1797346 PMID: 42294006

Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.

Chowdhury MMH, Quenum AJI, Rioux-Perreault C, Lucier JF, Ilangumaran S, Piché A, Allard-Chamard H, Ramanathan S

Scientific reports2026Senior author

DOI: 10.1038/s41598-026-46180-y PMID: 41998026

Essential Role of NLRC5 in Cancer Immune Surveillance and Cancer Immunoediting.

Shukla A, Cayarga AA, Lucier JF, Santharam MA, Quenum AJI, Ihsan AU, Lévesque D, Boisvert FM, Ramanathan S, Ilangumaran S

Scandinavian journal of immunology2025

DOI: 10.1111/sji.70047 PMID: 40820374

Editorial.

Ramanathan S, Vallinoto ACR

Cytokine2025First author

DOI: 10.1016/j.cyto.2025.156940 PMID: 40274498

P robiotics i nfluencing r esponse of a ntibodies over t ime in s eniors after CO VID-19 v accine (PIRATES-COV): a randomised controlled trial protocol.

Pasquier JC, Plourde M, Ramanathan S, Chaillet N, Boivin G, Laforest-Lapointe I, Allard-Chamard H, Baron G, Beaulieu JF, Fülöp T, Généreux M, Mâsse B, Robitaille J, Valiquette L, Bilodeau S, H Buch D, Piche A

BMJ open2025

DOI: 10.1136/bmjopen-2024-088231 PMID: 40107677

Impact of a tailored exercise regimen on physical capacity and plasma proteome profile in post-COVID-19 condition.

Chowdhury MMH, Fontaine MN, Lord SE, Quenum AJI, Limoges MA, Rioux-Perreault C, Lucier JF, Cliche DO, Levesque D, Boisvert FM, Cantin AM, Allard-Chamard H, Menendez A, Ilangumaran S, Piché A, Dionne IJ, Ramanathan S

Frontiers in physiology2024Senior author

DOI: 10.3389/fphys.2024.1416639 PMID: 39234310

Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon tetrachloride-induced liver fibrosis model.

Cloutier M, Variya B, Akbari SA, Rexhepi F, Ilangumaran S, Ramanathan S

Frontiers in immunology2024Senior author

DOI: 10.3389/fimmu.2024.1404891 PMID: 38919611

Something wrong or missing on this profile? Suggest a correction

Sheela Ramanathan

Research

Latest papers

Latest funding

Effect of probiotics on humoral responses to COVID-19 vaccination in older adults: a randomized, placebo-controlled trial (PIRATES-COV study).

Trans-Presentation of IL-15 by IL15R&#x3b1; Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.

NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.

Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.

Distinct plasma proteome signature at 3&#xa0;months post-COVID-19 infection irrespective of post-COVID condition.

Essential Role of NLRC5 in Cancer Immune Surveillance and Cancer Immunoediting.

Editorial.

P robiotics i nfluencing r esponse of a ntibodies over t ime in s eniors after CO VID-19 v accine (PIRATES-COV): a randomised controlled trial protocol.

Impact of a tailored exercise regimen on physical capacity and plasma proteome profile in post-COVID-19 condition.

Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon tetrachloride-induced liver fibrosis model.

Frequent collaborators

Subburaj Ilangumaran

Alfredo Menendez

Hugues Allard-Chamard

Caroline Saucier

Marie-France Langlois

Julie Fradette

Louis-Charles Fortier

Julie Robitaille

Gerardo Ferbeyre

Jana Stankova

Isabelle Laforest-Lapointe

Gerardo Ferbeyre

Marek Rola-Pleszczynski

Guy Boivin

Gerardo Ferbeyre

Trang Hoang

Nathalie Rivard

Sophie Roux

Adel Schwertani

Nathalie Perreault

Christine Lavoie

Marie-Claude Beaulieu

Alain Piche

Claire Dubois

Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.

Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.